Accordingly, there is clinical prospect for pharmacological targeting of OPN, combined with other anticancer therapies, to overcome the obstacle of treatment of advanced cancers including chemotherapeutics, radio therapeutics as well as molecular targeted therapeutics towards resistance cancers, but more studies are necessary to confirm the clinical significance of OPN in cancer response to conventional therapy. The gene discussed is SPP1; the disease is cancer.